Literature DB >> 9359838

Inositol 1,4,5-trisphosphate receptor subtypes differentially recognize regioisomers of D-myo-inositol 1,4,5-trisphosphate.

M Hirata1, H Takeuchi, A M Riley, S J Mills, Y Watanabe, B V Potter.   

Abstract

The Ins(1,4,5)P3 regioisomers, Ins(1,4,6)P3 and Ins(1,3,6)P3, which can mimic the 1,4,5-arrangement on the inositol ring of Ins(1,4,5)P3, were examined for Ca2+ release by using four types of saponin-permeabilized cell possessing various abundances of receptor subtypes, with special reference to the relation of potency to receptor subtype. Ins(1,4,6)P3 and Ins(1,3,6)P3 were weak agonists in rat basophilic leukaemic cells (RBL cells), which possess predominantly subtype II receptors, with respective potencies of 1/200 and less than 1/500 that of Ins(1,4,5)P3 [the EC50 values were 0.2, 45 and more than 100 microM for Ins(1,4,5)P3, Ins(1,4,6)P3 and Ins(1,3,6)P3 respectively]. Similar rank order potencies were also evaluated for the displacement of [3H]Ins(1,4,5)P3 bound to RBL cell membranes by these regioisomers. However, they caused Ca2+ release from GH3 rat pituitary cells possessing predominantly subtype I receptors more potently; Ins(1,4,6)P3 and Ins(1,3,6)P3 evoked release at respective concentrations of only one-third and one-twentieth that of Ins(1,4,5)P3 (the EC50 values were 0.4, 1.2 and 8 microM for Ins(1,4,5)P3, Ins(1,4,6)P3 and Ins(1,3,6)P3 respectively). In COS-1 African green-monkey kidney cells, with the relative abundances of 37% of the subtype II and of 62% of the subtype III receptor, potencies of 1/40 and approx. 1/200 for Ins(1, 4,6)P3 and Ins(1,3,6)P3 respectively were exhibited relative to Ins(1,4,5)P3 (the EC50 values were 0.4, 15 and approx. 80 microM for Ins(1,4,5)P3, Ins(1,4,6)P3 and Ins(1,3,6)P3 respectively). In HL-60 human leukaemic cells, in spite of the dominant presence of subtype I receptors (71%), similar respective potencies to those seen with COS-1 cells were exhibited (the EC50 values were 0.3, 15 and approx. 100 microM for Ins(1,4,5)P3, Ins(1,4,6)P3 and Ins(1,3,6)P3 respectively). These results indicate that these regioisomers are the first ligands that distinguish between receptor subtypes; the present observations are of significance for the future design of molecules with enhanced selectivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359838      PMCID: PMC1218891          DOI: 10.1042/bj3280093

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

Review 1.  Inositol trisphosphate and diacylglycerol: two interacting second messengers.

Authors:  M J Berridge
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

2.  Heterotetrameric complex formation of inositol 1,4,5-trisphosphate receptor subunits.

Authors:  T Monkawa; A Miyawaki; T Sugiyama; H Yoneshima; M Yamamoto-Hino; T Furuichi; T Saruta; M Hasegawa; K Mikoshiba
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

3.  Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types.

Authors:  R J Wojcikiewicz
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

4.  Purification and characterization of the human type 1 Ins(1,4,5)P3 receptor from platelets and comparison with receptor subtypes in other normal and transformed blood cells.

Authors:  F O'Rourke; E Matthews; M B Feinstein
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

5.  Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP3) receptors with distinct affinities for InsP3.

Authors:  C L Newton; G A Mignery; T C Südhof
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

6.  Calcium as a coagonist of inositol 1,4,5-trisphosphate-induced calcium release.

Authors:  E A Finch; T J Turner; S M Goldin
Journal:  Science       Date:  1991-04-19       Impact factor: 47.728

7.  Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.

Authors:  C T Murphy; A J Bullock; C J Lindley; S J Mills; A M Riley; B V Potter; J Westwick
Journal:  Mol Pharmacol       Date:  1996-11       Impact factor: 4.436

8.  Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes.

Authors:  M Hirata; Y Watanabe; M Yoshida; T Koga; S Ozaki
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

9.  The inositol phosphates in WRK1 rat mammary tumour cells.

Authors:  N S Wong; C J Barker; A J Morris; A Craxton; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

10.  Structure of a novel InsP3 receptor.

Authors:  T C Südhof; C L Newton; B T Archer; Y A Ushkaryov; G A Mignery
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more
  2 in total

1.  Selective recognition of inositol phosphates by subtypes of the inositol trisphosphate receptor.

Authors:  E P Nerou; A M Riley; B V Potter; C W Taylor
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

2.  Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes.

Authors:  Roland B Gregory; Rachael Hughes; Andrew M Riley; Barry V L Potter; Robert A Wilcox; Greg J Barritt
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.